New SMARCA4 Mutation Linked to Coffin-Siris Syndrome Type 4 with Autism but Without Visual Impairment
Rare Genetic Mutation Identified in Young Patient
A recent case study has reported a novel mutation in the SMARCA4 gene associated with Coffin-Siris syndrome type 4 (CSS4), presenting alongside autism spectrum disorder (ASD) but notably lacking visual impairment or the typical fifth digit abnormalities. This finding expands the known clinical spectrum of CSS4 and highlights the importance of genetic testing in children with developmental delays and ASD features.
Details of the Case and Genetic Findings
The subject of the study is a 3-year-old Chinese girl exhibiting global developmental delays and characteristics consistent with ASD. Despite having distinctive facial features commonly linked to CSS4, she did not show the classic hypoplasia (underdevelopment) of the fifth fingers nor any structural eye anomalies upon thorough ophthalmologic examination.
Whole-exome sequencing revealed a previously unreported heterozygous de novo frameshift duplication mutation in SMARCA4, specifically c.4767dup (p.Ser1590Ilefs*39). This mutation affects the BRG1 ATPase subunit of the BAF chromatin-remodeling complex, which plays a crucial role in gene regulation.
Broader Context from Literature Review
The researchers conducted a systematic review of 39 genetically confirmed cases of SMARCA4-related CSS4, combining these with their patient for a total of 40 cases. Intellectual disability was a consistent feature across all cases. Autism spectrum disorder was present in approximately 42.5% of patients, while only about 55% exhibited the hallmark fifth digit hypoplasia.
Interestingly, truncating mutations—such as the one found in this patient—were associated with a trend toward more frequent fifth digit and ocular anomalies compared to missense mutations, although these differences were not statistically significant. The current case challenges this trend by demonstrating that even truncating mutations can present without classic digital or eye abnormalities.
Implications for Diagnosis and Care
This case underscores the variability in clinical presentation of CSS4 and suggests that genetic testing for mutations in SWI/SNF complex genes like SMARCA4 should be considered in children with developmental delays and ASD, regardless of the presence of typical physical features such as fifth digit hypoplasia.
Moreover, given limited data, individuals with truncating SMARCA4 variants may carry a potential risk for tumor development, warranting cautious counseling and possibly tailored surveillance strategies until further research clarifies these risks.
Limitations and Future Directions
While the study provides valuable insights, the small number of documented cases limits definitive conclusions about genotype-phenotype correlations. Further research is needed to better understand the full spectrum of clinical features associated with SMARCA4 mutations and to develop evidence-based guidelines for monitoring and management.
For more detailed information, the original study can be accessed here.